B-cell proliferation and differentiation in systemic lupus erythematosus and mixed connective tissue disease
- PMID: 3264025
B-cell proliferation and differentiation in systemic lupus erythematosus and mixed connective tissue disease
Abstract
Systemic lupus erythematosus (SLE) and mixed connective tissue disease (MCTD) are characterized by B-cell hyperactivity as manifested by spontaneous in vitro production of immunoglobulins (Ig), but pokeweed mitogen (PWM)-induced Ig synthesis of peripheral blood (PB) mononuclear cells, a T-cell dependent process, is markedly decreased. We analyzed the defective capacity to produce Ig in vitro in 11 patients with SLE and 11 with MCTD. PWM-activated PB T-cells, both from SLE- and MCTD-patients, did not differ from control T-cells in their capacity to produce B-cell growth factors (BCGF) and B-cell differentiation factors (BCDF). However, B-cell proliferative responsiveness to control T-cell factors was decreased compared to control B-cells (p less than 0.01). In contrast to PB B-cells splenic B-cells from a patient with MCTD who underwent splenectomy were highly responsive to T-cell factors in a dose dependent way. It is concluded that the defective PWM-induced Ig production of PB lymphocytes in SLE/MCTD is due to decreased responsiveness of PB B cells to T-cell factors. However, analysis of splenic lymphocytes may be more representative for evaluation of the immunoregulatory disturbances in these disorders.
Similar articles
-
Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells in systemic lupus erythematosus.Clin Exp Immunol. 1979 Jan;35(1):76-88. Clin Exp Immunol. 1979. PMID: 154983 Free PMC article.
-
Heterogeneity of B cell responsiveness to interleukin 4, interleukin 6 and low molecular weight B cell growth factor in discrete stages of B cell activation in patients with systemic lupus erythematosus.Clin Exp Immunol. 1989 Jul;77(1):31-6. Clin Exp Immunol. 1989. PMID: 2788539 Free PMC article.
-
Stimulating and differentiation factors for human B lymphocytes in systemic lupus erythematosus.Clin Exp Immunol. 1986 Sep;65(3):598-604. Clin Exp Immunol. 1986. PMID: 3490941 Free PMC article.
-
B lymphocyte function in patients with rheumatoid arthritis: impact of regulatory T lymphocytes and macrophages--modulation by antirheumatic drugs.Dan Med Bull. 1988 Apr;35(2):140-57. Dan Med Bull. 1988. PMID: 3282810 Review.
-
[Role of T lymphocytes in systemic lupus erythematosus].Ann Med Interne (Paris). 1990;141(3):208-12. Ann Med Interne (Paris). 1990. PMID: 2195945 Review. French.
Cited by
-
T lymphocyte activation in systemic lupus erythematosus analysed by proliferative response to nucleoplasmic proteins on nitrocellulose immunoblots.Clin Exp Immunol. 1989 Aug;77(2):168-74. Clin Exp Immunol. 1989. PMID: 2789114 Free PMC article.
-
Cytokine-independent progression of immunoglobulin production in vitro by B lymphocytes from patients with systemic lupus erythematosus.Clin Exp Immunol. 1991 Feb;83(2):274-9. doi: 10.1111/j.1365-2249.1991.tb05627.x. Clin Exp Immunol. 1991. PMID: 1825187 Free PMC article.
-
B cell activation in clinically quiescent systemic lupus erythematosus (SLE) is related to immunoglobulin levels, but not to levels of anti-dsDNA, nor to concurrent T cell activation.Clin Exp Immunol. 1993 Jul;93(1):39-44. doi: 10.1111/j.1365-2249.1993.tb06494.x. Clin Exp Immunol. 1993. PMID: 8100746 Free PMC article.
-
Abnormal production of B cell growth factor in patients with systemic lupus erythematosus.Clin Exp Immunol. 1992 Jul;89(1):26-31. doi: 10.1111/j.1365-2249.1992.tb06872.x. Clin Exp Immunol. 1992. PMID: 1628424 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical